Zoë Weaver Ohler
- Oncology top 2%
- Cancer-related Molecular Pathways 6
- Lung Cancer Research Studies 4
- Genetics top 2%
- Glioma Diagnosis and Treatment 4
- BRCA gene mutations in cancer 3
- Chronic Lymphocytic Leukemia Research 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 4
- Molecular Biology top 5%
- DNA Repair Mechanisms 12
- Cell Biology top 5%
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Chu‐Xia DengXiaoling XuThomas RiedCuiling LiAnthony Wynshaw‐BorisXin Wei WangSteven P. LinkeDenise M. Larson
- Cited by
- OncologyGeneticsCancer Research
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (1 paper)Nature Genetics (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Zoë Weaver Ohler
38 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 1.0k
- Genetics 929
- Cancer Research 465
- Molecular Biology 2.0k
- Cell Biology 350
Countries citing papers authored by Zoë Weaver Ohler
This map shows the geographic impact of Zoë Weaver Ohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoë Weaver Ohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoë Weaver Ohler more than expected).
Fields of papers citing papers by Zoë Weaver Ohler
This network shows the impact of papers produced by Zoë Weaver Ohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoë Weaver Ohler. The network helps show where Zoë Weaver Ohler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zoë Weaver Ohler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 60 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 3 | |
| 7 | 2019 | 43 | |
| 8 | 2016 | 31 | |
| 9 | 2016 | 36 | |
| 10 | 2014 | 15 | |
| 11 | 2014 | 31 | |
| 12 | 2012 | 31 | |
| 13 | Antiangiogenic properties of the IMPDH inhibitor AVN944 | 2007 | 2 |
| 14 | 2005 | 10 | |
| 15 | 2001 | 131 | |
| 16 | 2000 | 59 | |
| 17 | Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient Cellsbreakdown → | 1999 | 668 |
| 18 | Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formationbreakdown → | 1999 | 595 |
| 19 | 1998 | 51 | |
| 20 | 1998 | 70 |
About Zoë Weaver Ohler
Zoë Weaver Ohler is a scholar working on Oncology, Genetics and Cancer Research, having authored 41 papers that have together received 2.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (12 papers), Cancer-related Molecular Pathways (6 papers), Glioma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Lung Cancer Research Studies (4 papers), BRCA gene mutations in cancer (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (1.0k citations), Genetics (929 citations) and Cancer Research (465 citations). Zoë Weaver Ohler has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Chu‐Xia Deng, Xiaoling Xu, Thomas Ried, Cuiling Li, Anthony Wynshaw‐Boris, Xin Wei Wang, Steven P. Linke, Denise M. Larson, Lothar Hennighausen and Kay‐Uwe Wagner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.